Basaglar 100 Unit (Insulin Glargine SOLUTION) 100 UNIT

BASAGLAR 100 Unit is a subcutaneous solution containing insulin glargine, designed for managing blood glucose levels in diabetes. This long-acting insulin helps regulate insulin levels over an extended period.

Strength

100 UNIT

Pack Size

3ML

Manufacturer / TM Owner

ELI LILLY CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BASAGLAR 100 Unit is primarily used for the management of diabetes mellitus. It helps control blood sugar levels in adults and children with type 1 and type 2 diabetes. This insulin glargine solution is administered subcutaneously to provide a steady release of insulin throughout the day, supporting glucose regulation.

Side Effects

Common effects of BASAGLAR 100 Unit may include mild redness or itching at the injection site. Some users might experience hypoglycemia, characterized by symptoms such as sweating, dizziness, or shakiness. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

BASAGLAR 100 Unit should be handled with care to avoid contamination. It is essential to store it properly to maintain its effectiveness. Users should monitor their blood sugar levels regularly and consult a healthcare provider for any concerns. Avoid sharing needles or syringes to prevent infection.

Avoid Interactions

BASAGLAR 100 Unit may interact with other medications, including oral hypoglycemic agents, corticosteroids, and certain antidepressants. Alcohol consumption can also affect blood sugar levels, so it is advisable to monitor intake. Always inform healthcare providers about all medications being taken to avoid potential interactions.

Frequently Asked Questions

BASAGLAR 100 Unit is used for managing blood glucose levels in individuals with diabetes mellitus.

BASAGLAR 100 Unit is administered subcutaneously, typically once daily.

Common side effects may include mild redness or itching at the injection site and symptoms of hypoglycemia.

BASAGLAR 100 Unit may interact with other diabetes medications, so it is important to consult a healthcare provider before combining treatments.

BASAGLAR 100 Unit should be stored in a refrigerator between 2°C to 8°C and protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.